Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

Is whole-brain radiotherapy still a standard treatment for primary central nervous system lymphomas?

Schlegel U, Korfel A.

Curr Opin Neurol. 2018 Dec;31(6):733-739. doi: 10.1097/WCO.0000000000000619. Review.

PMID:
30300241
2.

The Diagnosis and Treatment of Primary CNS Lymphoma.

von Baumgarten L, Illerhaus G, Korfel A, Schlegel U, Deckert M, Dreyling M.

Dtsch Arztebl Int. 2018 Jun 22;115(25):419-426. doi: 10.3238/arztebl.2018.0419.

3.

High-dose chemotherapy with autologous haematopoietic stem cell support for relapsed or refractory primary CNS lymphoma: a prospective multicentre trial by the German Cooperative PCNSL study group.

Kasenda B, Ihorst G, Schroers R, Korfel A, Schmidt-Wolf I, Egerer G, von Baumgarten L, Röth A, Bloehdorn J, Möhle R, Binder M, Keller U, Lamprecht M, Pfreundschuh M, Valk E, Fricker H, Schorb E, Fritsch K, Finke J, Illerhaus G.

Leukemia. 2017 Dec;31(12):2623-2629. doi: 10.1038/leu.2017.170. Epub 2017 May 31.

PMID:
28559537
4.

Early whole brain radiotherapy in primary CNS lymphoma: negative impact on quality of life in the randomized G-PCNSL-SG1 trial.

Herrlinger U, Schäfer N, Fimmers R, Griesinger F, Rauch M, Kirchen H, Roth P, Glas M, Bamberg M, Martus P, Thiel E, Korfel A, Weller M.

J Cancer Res Clin Oncol. 2017 Sep;143(9):1815-1821. doi: 10.1007/s00432-017-2423-5. Epub 2017 Apr 22.

5.

Case-based review: primary central nervous system lymphoma.

Korfel A, Schlegel U, Johnson DR, Kaufmann TJ, Giannini C, Hirose T.

Neurooncol Pract. 2017 Mar;4(1):46-59. doi: 10.1093/nop/npw033. Epub 2017 Feb 9. Review.

6.

The challenge of adequate imaging surveillance in primary central nervous system lymphoma.

Schlegel U, Korfel A.

Neuro Oncol. 2017 Mar 1;19(3):307-308. doi: 10.1093/neuonc/now273. No abstract available.

7.

How to facilitate early diagnosis of CNS involvement in malignant lymphoma.

Korfel A, Nowosielski M, Pardo-Moreno J, Penalver FJ, Buda G, Bennani H, Costopoulos M, Le Garff-Tavernier M, Soussain C, Schmid M, Orfao JA, Glantz M.

Expert Rev Hematol. 2016 Nov;9(11):1081-1091. Epub 2016 Oct 21. Review.

PMID:
27677656
8.

Identifying targetable genetic features in primary CNS lymphoma.

Korfel A, Schlegel U.

Int J Hematol Oncol. 2016 Nov;5(3):93-96. doi: 10.2217/ijh-2016-0012. Epub 2017 Jan 13. No abstract available.

9.

Osteopontin in cerebrospinal fluid as diagnostic biomarker for central nervous system lymphoma.

Strehlow F, Bauer S, Martus P, Weller M, Roth P, Schlegel U, Seidel S, Scheibenbogen C, Korfel A, Kreher S.

J Neurooncol. 2016 Aug;129(1):165-71. doi: 10.1007/s11060-016-2162-5. Epub 2016 Jun 13.

10.

Therapy for Secondary CNS Involvement in Malignant Lymphomas: No Standard Yet!

Korfel A, Chamberlain M, Neuwelt E, Thiel E, Doolittle N, Schlegel U, Dreyling M, Rubenstein J, Fischer L, Björkholm M, Martus P, Weller M, Glantz M.

J Clin Oncol. 2016 May 20;34(15):1829-30. doi: 10.1200/JCO.2015.65.0879. Epub 2016 Mar 21. No abstract available.

11.

Phase II Trial of Temsirolimus for Relapsed/Refractory Primary CNS Lymphoma.

Korfel A, Schlegel U, Herrlinger U, Dreyling M, Schmidt C, von Baumgarten L, Pezzutto A, Grobosch T, Kebir S, Thiel E, Martus P, Kiewe P.

J Clin Oncol. 2016 May 20;34(15):1757-63. doi: 10.1200/JCO.2015.64.9897. Epub 2016 Mar 14.

PMID:
26976424
12.

A focus on pharmacotherapy for primary central nervous system lymphoma.

Korfel A.

Expert Rev Hematol. 2015 Oct;8(5):559-62. doi: 10.1586/17474086.2015.1066672. Epub 2015 Jul 9.

PMID:
26159859
13.

[Primary CNS lymphoma. Progress in the diagnostics and therapy].

Korfel A, Schlegel U.

Nervenarzt. 2015 Jun;86(6):710-2, 714-5. doi: 10.1007/s00115-014-4227-z. Review. German.

PMID:
26013534
14.

Prognostic impact of B-cell lymphoma 6 in primary CNS lymphoma.

Kreher S, Jöhrens K, Strehlow F, Martus P, Borowiec K, Radke J, Heppner F, Roth P, Thiel E, Pietsch T, Weller M, Korfel A.

Neuro Oncol. 2015 Jul;17(7):1016-21. doi: 10.1093/neuonc/nov046. Epub 2015 Mar 26.

15.

[Special hematological diagnostics and therapy options for ocular lymphoma taking CNS involvement into account].

Korfel A, Schlegel U, Schroers R.

Ophthalmologe. 2015 Mar;112(3):231-6. doi: 10.1007/s00347-014-3207-9. Review. German.

PMID:
25721677
16.

Randomized phase III study of whole-brain radiotherapy for primary CNS lymphoma.

Korfel A, Thiel E, Martus P, Möhle R, Griesinger F, Rauch M, Röth A, Hertenstein B, Fischer T, Hundsberger T, Mergenthaler HG, Junghanß C, Birnbaum T, Fischer L, Jahnke K, Herrlinger U, Roth P, Bamberg M, Pietsch T, Weller M.

Neurology. 2015 Mar 24;84(12):1242-8. doi: 10.1212/WNL.0000000000001395. Epub 2015 Feb 25.

17.

Differentially regulated miRNAs as prognostic biomarkers in the blood of primary CNS lymphoma patients.

Roth P, Keller A, Hoheisel JD, Codo P, Bauer AS, Backes C, Leidinger P, Meese E, Thiel E, Korfel A, Weller M.

Eur J Cancer. 2015 Feb;51(3):382-90. doi: 10.1016/j.ejca.2014.10.028. Epub 2014 Dec 17.

18.

Prognostic impact of intraocular involvement in primary CNS lymphoma: experience from the G-PCNSL-SG1 trial.

Kreher S, Strehlow F, Martus P, Roth P, Hertenstein B, Röth A, Birnbaum T, Griesinger F, Rauch M, Kanz L, Thiel E, Weller M, Korfel A.

Ann Hematol. 2015 Mar;94(3):409-14. doi: 10.1007/s00277-014-2212-z. Epub 2014 Sep 13.

19.

A comprehensive analysis of the cellular and EBV-specific microRNAome in primary CNS PTLD identifies different patterns among EBV-associated tumors.

Fink SE, Gandhi MK, Nourse JP, Keane C, Jones K, Crooks P, Jöhrens K, Korfel A, Schmidt H, Neumann S, Tiede A, Jäger U, Dührsen U, Neuhaus R, Dreyling M, Borchert K, Südhoff T, Riess H, Anagnostopoulos I, Trappe RU.

Am J Transplant. 2014 Nov;14(11):2577-87. doi: 10.1111/ajt.12858. Epub 2014 Aug 4.

20.

Primary leptomeningeal lymphoma: International Primary CNS Lymphoma Collaborative Group report.

Taylor JW, Flanagan EP, O'Neill BP, Siegal T, Omuro A, Deangelis L, Baehring J, Nishikawa R, Pinto F, Chamberlain M, Hoang-Xuan K, Gonzalez-Aguilar A, Batchelor T, Blay JY, Korfel A, Betensky RA, Lopes MB, Schiff D.

Neurology. 2013 Nov 5;81(19):1690-6. doi: 10.1212/01.wnl.0000435302.02895.f3. Epub 2013 Oct 9.

21.

Brain and whole-body FDG-PET in diagnosis, treatment monitoring and long-term follow-up of primary CNS lymphoma.

Maza S, Buchert R, Brenner W, Munz DL, Thiel E, Korfel A, Kiewe P.

Radiol Oncol. 2013 May 21;47(2):103-10. doi: 10.2478/raon-2013-0016. Print 2013 Jun.

22.

Long-term cognitive function, neuroimaging, and quality of life in primary CNS lymphoma.

Doolittle ND, Korfel A, Lubow MA, Schorb E, Schlegel U, Rogowski S, Fu R, Dósa E, Illerhaus G, Kraemer DF, Muldoon LL, Calabrese P, Hedrick N, Tyson RM, Jahnke K, Maron LM, Butler RW, Neuwelt EA.

Neurology. 2013 Jul 2;81(1):84-92. doi: 10.1212/WNL.0b013e318297eeba. Epub 2013 May 17.

23.

Diagnosis and treatment of primary CNS lymphoma.

Korfel A, Schlegel U.

Nat Rev Neurol. 2013 Jun;9(6):317-27. doi: 10.1038/nrneurol.2013.83. Epub 2013 May 14. Review.

PMID:
23670107
24.

Phase II study of central nervous system (CNS)-directed chemotherapy including high-dose chemotherapy with autologous stem cell transplantation for CNS relapse of aggressive lymphomas.

Korfel A, Elter T, Thiel E, Hänel M, Möhle R, Schroers R, Reiser M, Dreyling M, Eucker J, Scholz C, Metzner B, Röth A, Birkmann J, Schlegel U, Martus P, Illerhaus G, Fischer L.

Haematologica. 2013 Mar;98(3):364-70. doi: 10.3324/haematol.2012.077917. Epub 2012 Dec 14.

25.

Central nervous system recurrence of systemic lymphoma in the era of stem cell transplantation--an International Primary Central Nervous System Lymphoma Study Group project.

Bromberg JE, Doorduijn JK, Illerhaus G, Jahnke K, Korfel A, Fischer L, Fritsch K, Kuittinen O, Issa S, van Montfort C, van den Bent MJ.

Haematologica. 2013 May;98(5):808-13. doi: 10.3324/haematol.2012.070839. Epub 2012 Nov 9.

26.

Surgery for primary CNS lymphoma? Challenging a paradigm.

Weller M, Martus P, Roth P, Thiel E, Korfel A; German PCNSL Study Group.

Neuro Oncol. 2012 Dec;14(12):1481-4. doi: 10.1093/neuonc/nos159. Epub 2012 Sep 14.

27.

Outcome of elderly patients with primary CNS lymphoma in the G-PCNSL-SG-1 trial.

Roth P, Martus P, Kiewe P, Möhle R, Klasen H, Rauch M, Röth A, Kaun S, Thiel E, Korfel A, Weller M.

Neurology. 2012 Aug 28;79(9):890-6. doi: 10.1212/WNL.0b013e318266fcb2. Epub 2012 Aug 15.

PMID:
22895585
28.

Pathogenesis and management of primary CNS lymphoma.

Roth P, Korfel A, Martus P, Weller M.

Expert Rev Anticancer Ther. 2012 May;12(5):623-33. doi: 10.1586/era.12.36. Review.

PMID:
22594897
29.

Prognostic impact of meningeal dissemination in primary CNS lymphoma (PCNSL): experience from the G-PCNSL-SG1 trial.

Korfel A, Weller M, Martus P, Roth P, Klasen HA, Roeth A, Rauch M, Hertenstein B, Fischer T, Hundsberger T, Leithäuser M, Birnbaum T, Kirchen H, Mergenthaler HG, Schubert J, Berdel W, Birkmann J, Hummel M, Thiel E, Fischer L.

Ann Oncol. 2012 Sep;23(9):2374-80. doi: 10.1093/annonc/mdr627. Epub 2012 Mar 5.

30.

Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma.

Deckert M, Engert A, Brück W, Ferreri AJ, Finke J, Illerhaus G, Klapper W, Korfel A, Küppers R, Maarouf M, Montesinos-Rongen M, Paulus W, Schlegel U, Lassmann H, Wiestler OD, Siebert R, DeAngelis LM.

Leukemia. 2011 Dec;25(12):1797-807. doi: 10.1038/leu.2011.169. Epub 2011 Aug 5. Review.

PMID:
21818113
31.

Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas.

Fischer L, Hummel M, Korfel A, Lenze D, Joehrens K, Thiel E.

Neuro Oncol. 2011 Oct;13(10):1090-8. doi: 10.1093/neuonc/nor107. Epub 2011 Jul 29.

32.

Prevention of central nervous system relapses in diffuse large B-cell lymphoma: which patients and how?

Korfel A.

Curr Opin Oncol. 2011 Sep;23(5):436-40. doi: 10.1097/CCO.0b013e3283499c7c. Review.

PMID:
21760506
33.

High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.

Thiel E, Korfel A, Martus P, Kanz L, Griesinger F, Rauch M, Röth A, Hertenstein B, von Toll T, Hundsberger T, Mergenthaler HG, Leithäuser M, Birnbaum T, Fischer L, Jahnke K, Herrlinger U, Plasswilm L, Nägele T, Pietsch T, Bamberg M, Weller M.

Lancet Oncol. 2010 Nov;11(11):1036-47. doi: 10.1016/S1470-2045(10)70229-1. Epub 2010 Oct 20.

PMID:
20970380
34.

Topotecan and ifosfamide systemic chemotherapy for CNS involvement of solid tumors.

Kiewe P, Thiel E, Reinwald M, Korfel A.

J Neurooncol. 2011 Jul;103(3):629-34. doi: 10.1007/s11060-010-0434-z. Epub 2010 Oct 13.

PMID:
20941526
35.

Non-enhancing relapse of a primary CNS lymphoma with multiple diffusion-restricted lesions.

Fischer L, Koch A, Schlegel U, Koch HC, Wenzel R, Schröder N, Thiel E, Korfel A.

J Neurooncol. 2011 Mar;102(1):163-6. doi: 10.1007/s11060-010-0287-5. Epub 2010 Jul 3.

PMID:
20602148
36.

Meningeal dissemination in primary CNS lymphoma: diagnosis, treatment, and survival in a large monocenter cohort.

Kiewe P, Fischer L, Martus P, Thiel E, Korfel A.

Neuro Oncol. 2010 Apr;12(4):409-17. doi: 10.1093/neuonc/nop053. Epub 2010 Jan 25.

37.

Genetic variants of folate and methionine metabolism and PCNSL incidence in a German patient population.

Kurzwelly D, Knop S, Guenther M, Loeffler J, Korfel A, Thiel E, Hebart H, Simon M, Weller M, Linnebank M, Herrlinger U.

J Neurooncol. 2010 Nov;100(2):187-92. doi: 10.1007/s11060-010-0154-4. Epub 2010 Mar 17.

PMID:
20237949
38.

Penetration of ifosfamide and its active metabolite 4-OH-ifosfamide into cerebrospinal fluid of patients with CNS malignancies.

Kiewe P, Neumann M, Wagner T, Seyfert S, Albrecht H, Thiel E, Korfel A.

Cancer Chemother Pharmacol. 2011 Jan;67(1):27-33. doi: 10.1007/s00280-010-1274-4. Epub 2010 Feb 24.

PMID:
20182727
39.

Phase I study of the novel, fully synthetic epothilone sagopilone (ZK-EPO) in patients with solid tumors.

Schmid P, Kiewe P, Possinger K, Korfel A, Lindemann S, Giurescu M, Reif S, Wiesinger H, Thiel E, Kühnhardt D.

Ann Oncol. 2010 Mar;21(3):633-9. doi: 10.1093/annonc/mdp491. Epub 2009 Oct 30.

PMID:
19880436
40.

CXCL13 and CXCL12 in central nervous system lymphoma patients.

Fischer L, Korfel A, Pfeiffer S, Kiewe P, Volk HD, Cakiroglu H, Widmann T, Thiel E.

Clin Cancer Res. 2009 Oct 1;15(19):5968-73. doi: 10.1158/1078-0432.CCR-09-0108. Epub 2009 Sep 22.

41.

Ifosfamide or trofosfamide in patients with intraocular lymphoma.

Jahnke K, Thiel E, Bechrakis NE, Willerding G, Kraemer DF, Fischer L, Korfel A.

J Neurooncol. 2009 Jun;93(2):213-7. doi: 10.1007/s11060-008-9761-8. Epub 2008 Dec 20.

PMID:
19099202
42.

First report on a prospective trial with yttrium-90-labeled ibritumomab tiuxetan (Zevalin) in primary CNS lymphoma.

Maza S, Kiewe P, Munz DL, Korfel A, Hamm B, Jahnke K, Thiel E.

Neuro Oncol. 2009 Aug;11(4):423-9. doi: 10.1215/15228517-2008-108. Epub 2008 Dec 5.

43.

Diffuse leukoencephalopathy and brain edema: unusual presentations of CNS relapse of acute myeloid leukemia.

Schumann M, Kiewe P, Hartlieb S, Neumann M, Schilling A, Koch HC, Thiel E, Korfel A.

J Neuroimaging. 2010 Apr;20(2):198-200. doi: 10.1111/j.1552-6569.2008.00300.x. Epub 2009 Sep 27.

PMID:
18826442
44.

Meningeal dissemination in primary CNS lymphoma: prospective evaluation of 282 patients.

Fischer L, Martus P, Weller M, Klasen HA, Rohden B, Röth A, Storek B, Hummel M, Nägele T, Thiel E, Korfel A.

Neurology. 2008 Sep 30;71(14):1102-8. doi: 10.1212/01.wnl.0000326958.52546.f5.

45.

Systemic high-dose methotrexate plus ifosfamide is highly effective for central nervous system (CNS) involvement of lymphoma.

Fischer L, Korfel A, Kiewe P, Neumann M, Jahnke K, Thiel E.

Ann Hematol. 2009 Feb;88(2):133-9. doi: 10.1007/s00277-008-0575-8. Epub 2008 Aug 5.

PMID:
18679681
46.

Primary CNS lymphoma and HLA class I and II alleles in a German cohort of immunocompetent patients.

Kurzwelly D, Müller CA, Korfel A, Thiel E, Linnebank M, Weller M, Herrlinger U.

J Neurooncol. 2008 Oct;90(1):53-5. doi: 10.1007/s11060-008-9630-5. Epub 2008 Jun 28.

47.

Primary central nervous system lymphoma: monocenter, long-term, intent-to-treat analysis.

Kiewe P, Fischer L, Martus P, Thiel E, Korfel A.

Cancer. 2008 Apr 15;112(8):1812-20. doi: 10.1002/cncr.23377.

48.

Isolated B-cell lymphoproliferative disorder at the dura mater with B-cell chronic lymphocytic leukemia immunophenotype.

Kiewe P, Dallenbach FE, Fischer L, Hoecht S, Kombos T, Thiel E, Korfel A.

Clin Lymphoma Myeloma. 2007 Nov;7(9):594-6.

PMID:
18186969
49.
50.

Diagnosis and management of primary intraocular lymphoma: an update.

Jahnke K, Thiel E, Abrey LE, Neuwelt EA, Korfel A.

Clin Ophthalmol. 2007 Sep;1(3):247-58.

Supplemental Content

Loading ...
Support Center